Pharma PR Newswire

Pharma Focus Asia offers the most advanced strategies in Pharmaceutical Sector, the most significant developments in the industry and provides information on the latest research in Pharma Healthcare. The following Press Releases highlights the recent happenings in the Pharmaceutical Sector across the world.

Xencor Announces Strategic Collaboration for Bispecific Programs, including XmAb 14045 and XmAb 13676

Tuesday, June 28, 2016 PR Newswire

MONROVIA Calif June 28 2016 PRNewswire Xencor IncXencor NASDAQXNCR announced today that it has entered into a collaboration and license agreement with Novartis to develop and commercialize novel therapeutics including XmAb14045 expected to begin clinical development for acute myeloid leukemia in 2..

Multinational ADOPT Study Seeks Further Improvement in Management of Oral Mucositis

Tuesday, June 28, 2016 PR Newswire

SINGAPORE June 28 2016 PRNewswire A new study titled ADOPT Awareness Drives Oral Mucositis PercepTive has highlighted an opportunity to improve the wellbeing of patients undergoing cancer treatment through stronger proactive management of oral mucositis OM OM is a common side effect of cancer tr..

Glide Technologies Announces Successful Clinical Proof-of-Concept Study with its Novel Octreotide Solid Dose Formulation Delivered via SDI®

Tuesday, June 28, 2016 PR Newswire

OXFORD England June 28 2016 PRNewswire Glide Technologies today announced results from a successful clinical proofofconcept study that demonstrated its novel solid formulation of the most widelyused dose of octreotide 100 mcg achieved bioequivalence to the currently marketed immediate release li..

Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition

Monday, June 27, 2016 PR Newswire

DUBLIN June 27 2016 PRNewswire Jazz Pharmaceuticals plc Nasdaq JAZZ announced that the waiting period under the HartScottRodino Antitrust Improvements Act of 1976 as amended HSR with respect to its proposed acquisition of Celator Pharmaceuticals Inc Celator Nasdaq CPXX expired effective June 24 2..

VMS Rehab Systems, Inc. Eyes Anomaly in Stock Price

Monday, June 27, 2016 PR Newswire

OTTAWA Ontario June 27 2016 PRNewswire VMS Rehab Systems Inc wwwvmsrehabsystemsinccom reported today that the Companys Board will take whatever measures required to build a strong and stable market for trading in the Companys stock which is currently listed on the OTC Marketspink current trading p..

New organization aims to break down barriers to effective recovery for opioid addiction

Monday, June 27, 2016 PR Newswire

WASHINGTON June 27 2016 PRNewswire Former US House Speaker Newt Gingrich Former US Representative Patrick J Kennedy and President of The Dream Corps Van Jones are partnering to launch Advocates for Opioid Recovery AOR a nonprofit organization dedicated to breaking down the barriers to proven effec..

inVentiv Health Selected By Pfizer As Preferred Provider For Global Clinical Services

Monday, June 27, 2016 PR Newswire

BURLINGTON Mass June 27 2016 PRNewswire inVentiv Health Inc a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of muchneeded therapies to market today announced that ithas beenselected by Pfizer Inc Pfizer as one of its preferred par..

Blueprint Bio Builds Executive Team with Major Appointment

Monday, June 27, 2016 PR Newswire

NEWPORT BEACH Calif June 27 2016 PRNewswire Blueprint Bio Inc a company dedicated to identifying validating protecting publishing and licensing new biological discoveries in the healthcare industry has announced that Edward Jensen will be joining the executive team effective immediately He ..

Biomedical Systems opens TECHNOLOGY AND RESEARCH CENTER

Monday, June 27, 2016 PR Newswire

ST LOUIS June 27 2016 PRNewswire Biomedical Systems a 40yearold familyowned leading clinical trial provider to Pharmaceutical Medical Device Biotech and Contract Research Organizations CROs has opened its new TECHNOLOGY AND RESEARCH CENTER in St Louis near the companys global headquarters The s..

Akcea Announces Publication of Positive Volanesorsen Clinical Data Showing Reduced Triglycerides and Improved Insulin Sensitivity in Patients with High Triglycerides and Type 2 Diabetes

Monday, June 27, 2016 PR Newswire

CAMBRIDGE Mass June 27 2016 PRNewswire Akcea Therapeutics a wholly owned subsidiary of Ionis Pharmaceuticals Inc NASDAQ IONS today announced the publication in Diabetes Care of positive clinical data from a Phase 2 study of volanesorsen in patients with high plasma triglyceride TG levels and type ..

AcelRx Pharmaceuticals Joins Russell 3000 and Russell 2000 Indexes

Monday, June 27, 2016 PR Newswire

REDWOOD CITY Calif June 27 2016 PRNewswire AcelRx Pharmaceuticals Inc Nasdaq ACRX a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain today announced that the company has joined the broadmarket Russell 3000..

Biosimilars Market Projected To Reach $41.7 Billion By 2024: Grand View Research, Inc.

Monday, June 27, 2016 PR Newswire

SAN FRANCISCO June 27 2016 PRNewswire Thebiosimilars marketis expected to reach USD 417 billion by 2024 according to a new report by Grand View Research Inc The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024 The most significant factor leadin..

Veracyte Named a San Francisco Bay Area 2016 \"Top Workplace\"

Monday, June 27, 2016 PR Newswire

SOUTH SAN FRANCISCO Calif June 27 2016 PRNewswire Veracyte Inc NASDAQ VCYT a molecular diagnostics company pioneering the field of molecular cytology today announced that it has been named to the Bay Area News Groups 2016 Top Workplaces list This is the third year in a row that Veracyte has receiv..

Why Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics

Monday, June 27, 2016 PR Newswire

NEW YORK June 27 2016 PRNewswire The Healthcare arena was one of the betterperforming sectors on Friday once again proving to be generally less sensitive to market downturns This morning StockCallerscom has noted four equities in the Biotech space for close examination Cerus Corp NASDAQ CERS Jun..

New analysis of INPULSIS™ trials demonstrates efficacy of OFEV® (nintedanib) across a range of IPF patients using broader diagnostic criteria

Monday, June 27, 2016 PR Newswire

RIDGEFIELD Conn June 27 2016 PRNewswire New analysis of the INPULSIS trials show for the first time that disease progression is similar in idiopathic pulmonary fibrosis IPF patients identified using a broader diagnostic definition compared with the current diagnostic guidelines The posthoc analysi..

VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate, VM202, in Painful Diabetic Peripheral Neuropathy

Monday, June 27, 2016 PR Newswire

ATLANTA June 27 2016 PRNewswire VM BioPharma the United States division of ViroMed Co Ltd in Seoul Korea KOSDAQ084990 today announced the first patient was dosed in the recently initiated Phase 3 clinical study evaluating VM202 a proprietary DNA based biopharmaceutical in patients with painful dia..

TFS Announces Appointment of Dr. Birgitte Volck as Non-Executive Board Member

Monday, June 27, 2016 PR Newswire

LUND Sweden June 27 2016 PRNewswire TFS International is pleased to announce the appointment of Dr Birgitte Volck as a nonexecutive Director to serve on the Companys Board of Directors Dr Volck is the Senior Vice President Head of RD Rare Disease at GlaxoSmithKline in the UK During the past 4 y..

Analysts View on Drug Manufacturers - Other Equities - Endo Intl., Teva Pharma, Synergy Pharma, and Orexigen Therapeutics

Monday, June 27, 2016 PR Newswire

NEW YORK June 27 2016 PRNewswire On Friday June 24 2016 the NASDAQ Composite ended the trading session at 470798 down 412 the Dow Jones Industrial Average declined 339 to finish at 1740075 and the SP 500 closed at 203741 down 359 StockCallerscom has initiated coverage on the following equities E..

Medimetriks Pharmaceuticals, Inc. Submits a New Drug Application to FDA for Ozenoxacin Cream, 1%, a Novel Impetigo Treatment

Monday, June 27, 2016 PR Newswire

FAIRFIELD NJ June 27 2016 PRNewswire Medimetriks Pharmaceuticals Inc announced today that it has submitted a New Drug Application NDA to the US Food and Drug Administration FDA seeking approval of ozenoxacin cream 1 a novel nonfluorinated quinolone for the treatment of impetigo Medimetriks license..

Biotechnology Equities at a Glance -- MannKind, bluebird bio, OncoGenex Pharma, and Hevat Biologics

Monday, June 27, 2016 PR Newswire

NEW YORK June 27 2016 PRNewswire On Friday June 24 2016 the NASDAQ Composite ended the trading session at 470798 down 412 the Dow Jones Industrial Average declined 339 to finish at 1740075 and the SP 500 closed at 203741 down 359 StockCallerscom has initiated coverage on the following equities M..

TOP